CLDN2 and breast cancer: To determine whether Claudin-2 was responsible for the observed increase in anchorage-independent growth, we stably diminished endogenous Claudin-2 levels in two aggressively liver metastatic 4T1 breast cancer cell populations using two independent Claudin-2 shRNA expression vectors (Fig. 1C; Tabariès et al. 2011).